tiprankstipranks
Trending News
More News >
Niagen Bioscience (NAGE)
NASDAQ:NAGE
US Market

Niagen Bioscience (NAGE) Ratios

Compare
625 Followers

Niagen Bioscience Ratios

NAGE's free cash flow for Q3 2025 was $0.65. For the 2025 fiscal year, NAGE's free cash flow was decreased by $ and operating cash flow was $0.14. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.12 3.57 2.40 2.61 2.78
Quick Ratio
3.29 3.06 1.70 1.78 2.00
Cash Ratio
2.82 2.48 1.32 1.13 1.59
Solvency Ratio
0.79 0.45 -0.12 -0.49 -0.92
Operating Cash Flow Ratio
0.94 0.67 0.35 -0.84 -1.37
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -21.69 -44.09
Net Current Asset Value
$ 66.15M$ 41.92M$ 23.03M$ 21.18M$ 22.79M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.04 0.06 0.08 0.08
Debt-to-Equity Ratio
0.04 0.06 0.12 0.15 0.15
Debt-to-Capital Ratio
0.04 0.05 0.10 0.13 0.13
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.39 1.48 1.93 1.89 1.82
Debt Service Coverage Ratio
0.00 0.00 0.00 -20.96 -39.60
Interest Coverage Ratio
0.00 0.00 0.00 -6.21K -492.24
Debt to Market Cap
0.00 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
0.03 0.03 0.05 0.06 0.07
Net Debt to EBITDA
-2.89 -4.54 6.14 0.95 0.92
Profitability Margins
Gross Profit Margin
63.89%61.84%60.76%59.40%61.51%
EBIT Margin
15.93%7.76%-6.70%-25.85%-40.14%
EBITDA Margin
16.95%9.25%-4.66%-23.24%-37.73%
Operating Profit Margin
15.48%7.76%-6.70%-25.85%-40.14%
Pretax Profit Margin
17.04%8.89%-5.91%-22.96%-40.22%
Net Profit Margin
16.38%8.58%-5.91%-20.05%-37.89%
Continuous Operations Profit Margin
16.38%8.58%-5.91%-22.96%-40.22%
Net Income Per EBT
96.13%96.56%100.00%87.36%94.21%
EBT Per EBIT
110.09%114.61%88.19%88.79%100.20%
Return on Assets (ROA)
20.82%12.52%-8.98%-26.73%-44.19%
Return on Equity (ROE)
34.58%18.55%-17.35%-50.39%-80.55%
Return on Capital Employed (ROCE)
25.59%15.35%-16.30%-51.48%-67.30%
Return on Invested Capital (ROIC)
24.29%14.53%-15.98%-43.30%-61.72%
Return on Tangible Assets
20.87%12.59%-9.07%-27.07%-44.85%
Earnings Yield
3.72%1.88%-4.90%-12.33%-10.17%
Efficiency Ratios
Receivables Turnover
14.66 12.82 15.97 8.49 12.91
Payables Turnover
3.53 4.46 3.20 3.02 2.49
Inventory Turnover
2.40 4.14 2.26 1.99 1.91
Fixed Asset Turnover
32.31 28.88 18.42 11.40 9.17
Asset Turnover
1.27 1.46 1.52 1.33 1.17
Working Capital Turnover Ratio
1.84 2.65 2.90 2.40 2.87
Cash Conversion Cycle
73.93 34.86 70.65 105.33 72.97
Days of Sales Outstanding
24.90 28.47 22.86 42.97 28.28
Days of Inventory Outstanding
152.32 88.27 161.68 183.13 191.24
Days of Payables Outstanding
103.29 81.87 113.90 120.77 146.55
Operating Cycle
177.22 116.73 184.54 226.10 219.52
Cash Flow Ratios
Operating Cash Flow Per Share
0.23 0.14 0.10 -0.22 -0.36
Free Cash Flow Per Share
0.23 0.14 0.10 -0.22 -0.37
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99 0.99 0.98 1.02 1.02
Dividend Paid and CapEx Coverage Ratio
82.34 74.29 48.09 -45.20 -59.08
Capital Expenditure Coverage Ratio
82.34 74.29 48.09 -45.20 -59.08
Operating Cash Flow Coverage Ratio
7.01 4.57 2.17 -3.55 -5.14
Operating Cash Flow to Sales Ratio
0.17 0.12 0.09 -0.21 -0.36
Free Cash Flow Yield
4.42%2.63%6.91%-13.17%-9.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
26.85 53.05 -20.43 -8.11 -9.83
Price-to-Sales (P/S) Ratio
3.83 4.55 1.21 1.63 3.73
Price-to-Book (P/B) Ratio
7.76 9.84 3.54 4.09 7.92
Price-to-Free Cash Flow (P/FCF) Ratio
22.60 37.97 14.48 -7.59 -10.23
Price-to-Operating Cash Flow Ratio
25.62 37.46 14.17 -7.76 -10.40
Price-to-Earnings Growth (PEG) Ratio
1.48 -0.22 0.29 0.18 -0.37
Price-to-Fair Value
7.76 9.84 3.54 4.09 7.92
Enterprise Value Multiple
19.72 44.71 -19.77 -6.04 -8.96
Enterprise Value
416.96M 411.74M 76.98M 101.16M 227.95M
EV to EBITDA
19.72 44.71 -19.77 -6.04 -8.96
EV to Sales
3.34 4.13 0.92 1.40 3.38
EV to Free Cash Flow
19.72 34.47 11.05 -6.56 -9.28
EV to Operating Cash Flow
19.48 34.00 10.82 -6.70 -9.43
Tangible Book Value Per Share
0.77 0.54 0.40 0.40 0.46
Shareholders’ Equity Per Share
0.77 0.54 0.40 0.41 0.47
Tax and Other Ratios
Effective Tax Rate
0.04 0.03 0.00 0.13 0.06
Revenue Per Share
1.36 1.17 1.18 1.03 1.00
Net Income Per Share
0.22 0.10 -0.07 -0.21 -0.38
Tax Burden
0.96 0.97 1.00 0.87 0.94
Interest Burden
1.07 1.15 0.88 0.89 1.00
Research & Development to Revenue
0.05 0.06 0.06 0.07 0.06
SG&A to Revenue
0.17 0.18 0.30 0.39 0.54
Stock-Based Compensation to Revenue
0.03 0.04 0.06 0.08 0.09
Income Quality
1.05 1.42 -1.44 0.91 0.89
Currency in USD